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Abstract
Background and aim: The DNA repair gene Ku70, an important member of non-homologous end-joining repair
system, is thought to play an important role in the repairing of DNA double strand breaks. It is known that defects
in double strand break repair capacity can lead to irreversible genomic instability. However, the polymorphic
variants of Ku70, have never been reported about their association with gastric cancer susceptibility.
Methods: In this hospital-based case-control study, the associations of Ku70 promoter T-991C (rs5751129),
promoter G-57C (rs2267437), promoter A-31G (rs132770), and intron 3 (rs132774) polymorphisms with gastric
cancer risk in a Taiwanese population were investigated. In total, 136 patients with gastric cancer and 560 age- and
gender-matched healthy controls recruited from the China Medical Hospital in Taiwan were genotyped.
Results: As for Ku70 promoter T-991C, the ORs after adjusted by age and gender of the people carrying TC and CC
genotypes were 2.41 (95% CI = 1.53-3.88) and 3.21 (95% CI = 0.96-9.41) respectively, compared to those carrying TT
wild-type genotype. The P for trend was significant (P < 0.0001). In the dominant model (TC plus CC versus TT), the
association between Ku70 promoter T-991C polymorphism and the risk for gastric cancer was also significant
(adjusted OR = 2.48, 95% CI = 1.74-3.92). When stratified by age and gender, the association was restricted to
those at the age of 55 or elder of age (TC vs TT: adjusted OR = 2.52, 95% CI = 1.37-4.68, P = 0.0139) and male (TC
vs TT: adjusted OR = 2.58, 95% CI = 1.33-4.47, P = 0.0085). As for the other three polymorphisms, there was no
difference between both groups in the distributions of their genotype frequencies.
Conclusion: In conclusion, the Ku70 promoter T-991C (rs5751129), but not the Ku70 promoter C-57G (rs2267437),
promoter A-31G (rs132770) or intron 3 (rs132774), is associated with gastric cancer susceptibility. This
polymorphism may be a novel useful marker for gastric carcinogenesis.
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Background
Gastric cancer is the fourth most common cancer over
the world and affects approximately 900,000 individuals
every year [1]. Although the identification of Helicobac-
ter pylori has revolutionized the understanding of its
epidemiology and pathogenesis, the initiation etiology
and genomic contributing factors of gastric cancer are
still largely unknown [2]. Human DNA repair mechan-
isms protect the genome from various insults caused by
endogenous and environmental agents [3], and muta-
tions or defects in the DNA repairing system are
thought to be essential for tumorigenesis [4,5]. There-
fore, it is logical to suspect that genetic variants of DNA
repair genes might contribute to gastric cancer
pathogenesis.
DNA double strand breaks (DSBs) are repaired by the
DNA DSB repair system [6,7], which consists of two
subpathways, homologous recombination (HR) and non-
homologous end-joining (NHEJ) [8]. In humans, NHEJ
is the predominant repair system. At present, several
proteins involved in the NHEJ pathway have been iden-
tified; namely, the ligase IV and its associated protein
XRCC4, the three components of the DNA dependent
protein kinase (DNA-PK) complex, Ku70, Ku80, and the
catalytic subunit PKcs [9]. Genetic variation in DNA
repair genes has been postulated as an important
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However, there is seldom information regarding gastric
cancer and DNA repair gene polymorphisms. As for
NHEJ, genetic polymorphisms influence DNA repair
capacity and confer predisposition to several cancers,
including skin [12], breast [13-15], bladder [16,17], and
oral cancers [18,19].
In our previous study, we have found that one poly-
morphism of XRCC4 DSB repair gene is associated with
gastric cancer susceptibility in Taiwan [20]. In this
study, we assumed that the upstream gene Ku70 in
NHEJ, like XRCC4, its polymorphisms may also contri-
bute to gastric carcinogenesis. To test this hypothesis,
we determined the genotypic frequency of four poly-
morphisms of the Ku70 gene at promoter T-991C
(rs5751129), promoter G-57C (rs2267437), promoter A-
31G (rs132770), and intron 3 (rs132774), using a poly-
merase chain reaction (PCR)-based restriction fragment
length polymorphism (RFLP) method. To the best of
our knowledge, this is the first study carried out to eval-
uate the contribution of Ku70 polymorphisms in gastric
oncology all over the world.
Methods
Study population and sample collection
One hundred and thirty six patients diagnosed with gas-
tric cancer were recruited at the outpatient clinics of
general surgery between 2005-2008 at the China Medi-
cal University Hospital, Taichung, Taiwan, Republic of
China. The mean age of the gastric cancer patients and
the controls were 51.4 (range = 38 to 79, SD = 9.3) and
52.2 (range = 41 to 77, SD = 7.6) years, respectively. All
patients voluntarily participated, completed a self-admi-
nistered questionnaire and provided peripheral blood
samples. Five hundred and sixty non-gastric cancer
healthy people as controls were selected by matching for
age and gender after initial random sampling from the
Health Examination Cohort of the hospital. Our study
was approved by the Institutional Review Board of the
China Medical University Hospital and written-informed
consent was obtained from all participants.
Genotyping conditions
Genomic DNA was prepared from peripheral blood leu-
cocytes using a QIAamp Blood Mini Kit (Blossom, Tai-
pei, Taiwan). The PCR cycling conditions were: one
cycle at 94°C for 5 min; 35 cycles of 94°C for 30 sec, 55°
C for 30 sec, and 72°C for 30 sec, and a final extension
at 72°C for 10 min. Pairs of PCR primer sequences and
restriction enzyme for each DNA product are all listed
in Table 1. Then, 10 ≥ of product was loaded into a 3%
agarose gel containing ethidium bromide for electro-
phoresis. Ten percent of the samples both in control
and patient groups were analyzed of their genotypes by
PCR direct sequencing (Genomics BioSci & Tech Co.,
Taipei) and the consistency is 100%.
Statistical analyses
To ensure that the controls used were representative of
the general population and to exclude the possibility of
genotyping error, the deviation of the genotype frequen-
cies of Ku70 single nucleotide polymorphisms in the
control subjects from those expected under the Hardy-
Weinberg equilibrium was assessed using the goodness-
of-fit test. Pearson’s Chi-square test or Fisher’se x a c t
test (when the expected number in any cell was less
than five) was used to compare the distribution of the
Ku70 genotypes between cases and controls. Cancer risk
associated with the genotypes was estimated as odds
ratio (ORs) and 95% confidence intervals (CIs) using
unconditional logistic regression. Data was recognized
as significant when the statistical P-value was less than
0.05.
Results
There were no significant differences between both
groups in their age, sex, and other cancer prevalence.
The frequencies of the genotypes of the Ku70 promoter
T-991C, promoter C-57G, promoter A-31G, and intron
3 polymorphisms in the gastric cancer and control
groups are shown in Table 2. The ORs after adjusted by
age and gender of the people carrying TC and CC geno-
types were 2.41 (95% CI = 1.53-3.88) and 3.21 (95% CI
Table 1 The primer sequences and restriction fragment length polymorphism conditions for Ku70 gene
polymorphisms
Polymorphism (location) Primers sequences (5’ to 3’) Restriction enzyme SNP sequence DNA fragment size (bp)
promoter T-991C
(rs5751129)
F: AACTCATGGACCCACGGTTGTGA
R: CAACTTAAATACAGGAATGTCTTG
Dpn II T
C
301
200 + 101
promoter G-57C
(rs2267437)
F: AACTCATGGACCCACGGTTGTGA
R: CAACTTAAATACAGGAATGTCTTG
Hae II C
G
298
195 + 103
promoter A-31G
(rs132770)
F: TACAGTCCTGACGTAGAAG
R: AAGCGACCAACTTGGACAGA
Mnl I G
A
226
146 + 80
intron 3
(rs132774)
F: GTATACTTACTGCATTCTGG
R: CATAAGTGCTCAGTACCTAT
Msc I G
C
160
114 + 46
*F and R indicate forward and reverse primers, respectively.
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Page 2 of 5= 0.96-9.41) respectively, compared to those carrying TT
wild-type genotype. The P for trend was significant (P <
0.0001). In the dominant model (TC plus CC versus
TT), the association between Ku70 promoter T-991C
polymorphism and the risk for gastric cancer was also
significant (adjusted OR = 2.48, 95% CI = 1.74-3.92). On
the contrary, as for the Ku70 promoter C-57G, promo-
ter A-31G, and intron 3 polymorphisms, the distribu-
tions of these polymorphisms were in Hardy-Weinberg
equilibrium but there was no difference between gastric
cancer and control groups in the distribution in the gen-
otype frequency at these SNP sites (Table 2).
We have further evaluated the genetic association
between gastric cancer in different age range and gender
by performing the stratification analysis of the Ku70 pro-
moter T-991C genotypes (Table 3). As for those people
under the age of 55, the distribution of the Ku70 promo-
ter T-991C genotypes was not significantly different
between case and control groups. Interestingly, an
increased risk was found in those people at the age of 55
or elder who carried TC genotype, compared with TT
genotype (adjusted OR = 2.52, 95% CI = 1.37-4.68, P =
0.0139) (Table 3). When data were stratified by gender,
the significantly increased risk was found in those male
carrying TC genotype, compared with TT genotype
(adjusted OR = 2.58, 95% CI = 1.33-4.47, P = 0.0085).
There was no difference found in female (Table 3).
Discussion
The present study is the first one to investigate the role
of Ku70 gene polymorphisms, which has never been
reported to be associated with gastric cancer risk. Our
study revealed that the Ku70 promoter T-991C poly-
morphism was associated with the susceptibility to gas-
tric cancer, but the C-57G, A-31G or intron 3
polymorphisms were not (Table 2), especially in those at
the age of 55 or elder, and in male (Table 3). In 2003,
Fu et al have reported that, Ku70 rs2267437 polymorph-
ism (which was called C-61G in their paper) was asso-
ciated with breast cancer risk [21]. It is reasonable that
we did not find a significant association of this SNP
with gastric cancer as they did in this SNP with breast
cancer in Taiwan population. Instead, we found that the
genotype of Ku70 rs2267437 was associated with gastric
cacner. Since Ku70 rs2267437 located in the promoter
region, its different genotypes may determine the differ-
ential expression level of Ku70 protein in the gastric tis-
sue. Thus, the genotypes of Ku70 promoter T-991C
Table 2 The associations between Ku70 polymorphisms and gastric cancer risk
Case (%) Control (%) Adjusted OR
a (95% CI) P-value
promoter T-991C (rs5751129)
TT 106 (77.9) 502 (89.6) 1.00 (ref)
TC 26 (19.1) 52 (9.3) 2.41 (1.53-3.88) 0.0020
CC 4 (3.0) 6 (1.1) 3.21 (0.96-9.41) 0.0837
P for trend 2.87 (1.37-5.02) <0.0001
(TC+CC) vs TT 2.48 (1.74-3.92) 0.0005
CC vs (TT+TC) 2.67 (0.71-9.69) 0.1114
Promoter G-57C (rs2267437)
CC 95 (69.9) 383 (68.4) 1.00 (ref)
CG 37 (27.2) 167 (29.8) 0.91 (0.48-1.38) 0.6722
GG 4 (2.9) 10 (1.8) 1.56 (0.55-4.97) 0.4954
P for trend 0.93 (0.53-3.34) 0.6164
(CG+GG) vs CC 0.98 (0.63-1.52) 0.8367
GG vs (CC+CG) 1.52 (0.58-5.01) 0.4917
promoter A-31G (rs132770)
GG 109 (80.1) 459 (82.0) 1.00 (ref)
GA 19 (14.0) 73 (13.0) 1.16 (0.71-1.93) 0.7763
AA 8 (5.9) 28 (5.0) 1.25 (0.51-2.68) 0.6642
P for trend 1.18 (0.68-2.34) 0.9065
(GA+AA) vs GG 1.14 (0.73-1.76) 0.6227
AA vs (GG+GA) 1.03 (0.37-3.01) 0.6673
intron 3 (rs132774)
GG 113 (83.1) 459 (82.0) 1.00 (ref)
GC 23 (16.9) 101 (18.0) 0.91 (0.60-1.73) 0.8040
CC 0 (0.0) 0 (0.0)
a Adjusted by age and gender; the line with ORs that significantly differ from 1.00 are bolded
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Ku70 in different stages, regulate the DNA repair capa-
city and overall genome stability, and play a role in gas-
tric carcinogenesis. Supporting the idea above, Hu et al
reported that the expression of TERT and Ku70 proteins
was significantly up-regulated in both precancerous
lesion and gastric cancer tissues and was significantly
higher in gastric cancer tissues than that in precancer-
ous lesions [22]. In the future, the correlation between
Ku70 rs5751129 genotype and phenotype still needs
further investigation. In addition to be associated with
oral cancer [18], Ku70 rs5751129 polymorphism was
also found to be associated with two-side pterygium
pathology, which are caused by an uncontrolled cell pro-
liferation like that of a tumor [23].
We have taken into consideration and tried our best
to conquer the limitations of this study. First, for the
possibility that some findings of further sub-grouping
are attributed to chance because of the limited num-
bers of patients, we just provided the main finding
with these 136 gastric patients and 560 (more than
four-fold of the number of the patients) non-cancer
controls, which is very convincing and reliable with
multiple-checked significances (P < 0.05 both in geno-
type and allelic frequencies, and those obvious odds
ratios and 95% CIs). Second, the false positive findings
are statistically explained by hidden population stratifi-
cation. But in this study, it seems unlikely that popula-
tion stratification is a major concern, for all the cases
and the controls recruited in this study were drawn
f r o mt h es a m eT a i w a n e s ee t h n i cg r o u pa n dt h eT a i w a -
nese population has relatively homogenous genetic
background [24]. Therefore, the potential confounding
effect of population stratification for genotyping data is
not a major concern. Third, the possible selection bias
was taken into consideration and reduced to a lowest
level by frequency matching on age and gender
between the cases and controls. Forth, from another
angle, the frequencies of Ku70 polymorphisms variant
alleles were similar to those reported in the NCBI
website in the Asian population studies, for example C
allele frequencies of Ku70 promoter T-991C are 5.7%
in our control group and 4.2~8.9% for Asian popula-
tions in NCBI, which suggest no selection bias for the
subject’s enrolments in terms of genotypes. Therefore,
the need for the present results of Ku70 promoter T-
991C to be verified in further larger gastric patient
population is not so urgent. Of course, further studies
in larger population and other functional repair assays
should be performed in the future for further findings,
particularly those among subgroups by clinical and
environmental factors, and clarify the mechanisms
involved.
In this study, the genotype distribution of the C allele
at Ku70 promoter T-991C was significantly higher in
the gastric cancer group (12.5%) than in the control
group (5.7%). It was also found that patients carrying
heterozygous TC for Ku70 promoter T-991C had a
2.41-fold higher risk of gastric cancer (Table 2). Combi-
nation of heterozygous and homozygous (TC or CC)
w a sa l m o s ta tt h es a m el e v e l( O R=2 . 4 8 )f o rg a s t r i c
cancer risk (Table 2). All these data suggested that the
Ca l l e l ea tKu70 promoter T-991C was a novel and
important biomarker for gastric carcinogenesis, and as
long as -991C was detected, the carriers were more sus-
ceptible to gastric cancer. As for the Ku70 promoter C-
57G, A-31G or intron 3 polymorphisms, our results
indicated that their genetic differences were not asso-
ciated with gastric cancer risk in Taiwanese population
(Table 2).
Conclusions
In conclusion, this is the first report to investigate the
association between Ku70 gene polymorphisms and gas-
tric cancer. Our findings suggested that Ku70 promoter
T-991C, but not Ku70 promoter C-57G, promoter A-
31G or intron 3 polymorphisms, was associated with
higher susceptibility to gastric cancer. The Ku70 promo-
ter T-991C polymorphism might become a potential
biomarker for the gastric oncology prediction and this
Table 3 Distribution of Ku70 promoter T-991C genotypes
stratified by age and gender in the gastric cancer and
control groups
Case (%) Control
(%)
Adjusted OR
a (95%
CI)
P-
value
Age
<5 5
TT 52 (80.0) 238 (90.8) 1.00 (ref)
TC 11 (16.9) 22 (8.4) 2.18 (0.97-4.88) 0.0600
CC 2 (3.1) 2 (0.8) 4.31 (0.69-27.33) 0.1551
≥ 55
TT 54 (76.1) 264 (88.6) 1.00 (ref)
TC 15
(21.1)
30 (10.1) 2.52 (1.37-4.68) 0.0139
CC 2 (2.8) 4 (1.3) 2.61 (0.51-11.62) 0.2776
Gender
Male
TT 69 (76.7) 336 (89.1) 1.00 (ref)
TC 18
(20.0)
36 (9.6) 2.58 (1.33-4.47) 0.0085
CC 3 (3.3) 5 (1.3) 2.85 (0.71-11.36) 0.1477
Female
TT 37 (80.4) 166 (90.7) 1.00 (ref)
TC 8 (17.4) 16 (8.7) 2.13 (0.79-6.03) 0.1019
CC 1 (2.2) 1 (0.6) 4.07 (0.31-69.45) 0.3371
a Adjusted by age and gender when appropriate; the line with ORs that
significantly differ from 1.00 are bolded
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tric carcinogenesis.
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